CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Large Decline in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDL) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 125,300 shares, a drop of 21.3% from the January 31st total of 159,300 shares. Based on an average daily volume of 41,278,100 shares, the days-to-cover ratio is presently 0.0 days.

CBD Life Sciences Price Performance

CBD Life Sciences stock traded down $0.00 during midday trading on Tuesday, hitting $0.00. 67,938,865 shares of the company were exchanged, compared to its average volume of 22,107,352. CBD Life Sciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.03.

About CBD Life Sciences

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.